Generate a tailored SOP for Dr. Kathleen Davern. Improve your application with a focused, well-structured draft.
Kathy Davern, BAppSc, MSc, moved to Western Australia in 2005 to establish and manage a world-class Monoclonal Antibody (MAb) Facility. The facility currently employs five staff and provides antibody-related services to researchers and commercial and government groups, both in Australia and internationally. Kathy holds a concurrent appointment as Research Manager at Perkins, overseeing research management-related aspects of the Institute. Prior to moving to WA, Kathy worked for 20 years at the Walter Eliza Hall Institute of Medical Research (WEHI) in Melbourne and at the Scripps Clinic Research Foundation in La Jolla, California. During her time at WEHI, Kathy worked in the fields of immunology and immunoparasitology with professors Sir Gustav Nossal, Graham Mitchell, and Graham Brown. Her research on schistosomiasis involved collaboration lasting 15 years with Prof. Edito Garcia and Wilfred Tiu at the College of Public Health in Manila, Philippines, which resulted in the identification of an important schistosome antigen, Sj26, used globally as a basis for pGEX fusion protein vectors. Since its inception, the MAb Facility has attracted a wide range of projects from various clients, with current projects including the production of antibodies and molecules involved in cancer, diabetes, immune regulation, and the development of novel approaches for the detection and neutralization of components from Australian snake venoms and cane toad toxin.
University of Western Australia • Perth, Australia
Manage the Monoclonal Antibody Facility and oversee research management aspects.
Requirements are standardized across the Graduate School for most Master by Coursework programs at UWA.